Kewalramani Reshma
CIK 0001735944 Name as filed on the most recent filing
Filed as Kewalramani Reshma (30)
79 transaction lines · from 30 filings · filed 2018-10-09 to 2026-03-03 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
79 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2026-02-27 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 15,580 disposed | 495.38 | 7,718,020.40 | Form 4, filing 0000875320-26-000129 | |
| 2026-02-27 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 5,995 disposed | 496.16 | 2,974,479.20 | Form 4, filing 0000875320-26-000129 | |
| 2026-02-27 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 3,498 disposed | 494.33 | 1,729,166.34 | Form 4, filing 0000875320-26-000129 | |
| 2026-02-27 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 3,278 disposed | 488.27 | 1,600,549.06 | Form 4, filing 0000875320-26-000129 | |
| 2026-02-27 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 2,725 disposed | 490.54 | 1,336,721.50 | Form 4, filing 0000875320-26-000129 | |
| 2026-02-27 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 2,520 disposed | 493.29 | 1,243,090.80 | Form 4, filing 0000875320-26-000129 | |
| 2026-02-27 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 2,510 disposed | 487.13 | 1,222,696.30 | Form 4, filing 0000875320-26-000129 | |
| 2026-02-27 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 1,725 disposed | 496.95 | 857,238.75 | Form 4, filing 0000875320-26-000129 | |
| 2026-02-27 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 949 disposed | 491.30 | 466,243.70 | Form 4, filing 0000875320-26-000129 | |
| 2026-02-27 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 460 disposed | 489.32 | 225,087.20 | Form 4, filing 0000875320-26-000129 | |
| 2026-02-27 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 400 disposed | 479.75 | 191,900.00 | Form 4, filing 0000875320-26-000129 | |
| 2026-02-27 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 240 disposed | 482.84 | 115,881.60 | Form 4, filing 0000875320-26-000129 | |
| 2026-02-27 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 120 disposed | 481.50 | 57,780.00 | Form 4, filing 0000875320-26-000129 | |
| 2025-08-06 |
Vertex Pharmaceuticals Inc / MA VRTX |
P, Open-market purchase | 5,710 acquired | 389.95 | 2,226,614.50 | Form 4, filing 0000875320-25-000220 | |
| 2025-08-06 |
Vertex Pharmaceuticals Inc / MA VRTX |
P, Open-market purchase | 4,290 acquired | 389.08 | 1,669,153.20 | Form 4, filing 0000875320-25-000220 | |
| 2024-11-08 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 15,198 disposed | 515.00 | 7,826,970.00 | Form 4, filing 0000875320-24-000225 | |
| 2024-07-30 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 15,202 disposed | 505.00 | 7,677,010.00 | Form 4, filing 0000875320-24-000195 | |
| 2024-07-22 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 15,202 disposed | 497.00 | 7,555,394.00 | Form 4, filing 0000875320-24-000187 | |
| 2024-05-24 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 1,565 disposed | 457.00 | 715,205.00 | Form 4, filing 0000875320-24-000160 | |
| 2024-05-20 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 15,202 disposed | 447.00 | 6,795,294.00 | Form 4, filing 0000875320-24-000156 | |
| 2023-12-15 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 17,135 disposed | 407.00 | 6,973,945.00 | Form 4, filing 0000875320-23-000062 | |
| 2023-12-13 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 5,098 disposed | 397.00 | 2,023,906.00 | Form 4, filing 0000875320-23-000058 | |
| 2023-11-13 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 5,097 disposed | 377.00 | 1,921,569.00 | Form 4, filing 0000875320-23-000035 | |
| 2023-07-17 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 7,828 disposed | 355.00 | 2,778,940.00 | Form 4, filing 0001209191-23-042557 | |
| 2023-04-27 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 1,668 disposed | 339.43 | 566,169.24 | Form 4, filing 0001209191-23-026270 | |
| 2023-04-27 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 1,611 disposed | 338.69 | 545,629.59 | Form 4, filing 0001209191-23-026270 | |
| 2023-04-27 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 38 disposed | 340.19 | 12,927.22 | Form 4, filing 0001209191-23-026270 | |
| 2023-01-25 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 10,000 disposed | 315.05 | 3,150,500.00 | Form 4, filing 0001209191-23-005219 | |
| 2022-08-15 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 11,689 disposed | 305.06 | 3,565,846.34 | Form 4, filing 0000899243-22-029032 | |
| 2022-06-24 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 11,689 disposed | 291.30 | 3,405,005.70 | Form 4, filing 0000899243-22-024385 | |
| 2021-08-19 |
Vertex Pharmaceuticals Inc / MA VRTX |
P, Open-market purchase | 5,757 acquired | 195.14 | 1,123,420.98 | Form 4, filing 0001209191-21-052881 | |
| 2021-08-19 |
Vertex Pharmaceuticals Inc / MA VRTX |
P, Open-market purchase | 4,243 acquired | 196.34 | 833,070.62 | Form 4, filing 0001209191-21-052881 | |
| 2020-08-06 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 870 disposed | 270.36 | 235,213.20 | Form 4, filing 0001209191-20-045935 | |
| 2020-08-06 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 487 disposed | 272.76 | 132,834.12 | Form 4, filing 0001209191-20-045935 | |
| 2020-08-06 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 471 disposed | 271.42 | 127,838.82 | Form 4, filing 0001209191-20-045935 | |
| 2020-08-06 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 152 disposed | 269.11 | 40,904.72 | Form 4, filing 0001209191-20-045935 | |
| 2020-08-06 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 93 disposed | 273.27 | 25,414.11 | Form 4, filing 0001209191-20-045935 | |
| 2020-05-15 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 27 disposed | 286.07 | 7,723.89 | Form 4, filing 0001209191-20-030498 | |
| 2020-05-15 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 19 disposed | 287.63 | 5,464.97 | Form 4, filing 0001209191-20-030498 | |
| 2020-05-15 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 10 disposed | 283.76 | 2,837.60 | Form 4, filing 0001209191-20-030498 | |
| 2020-05-15 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 9 disposed | 288.37 | 2,595.33 | Form 4, filing 0001209191-20-030498 | |
| 2020-05-15 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 9 disposed | 280.47 | 2,524.23 | Form 4, filing 0001209191-20-030498 | |
| 2020-05-15 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 7 disposed | 279.70 | 1,957.90 | Form 4, filing 0001209191-20-030498 | |
| 2020-05-15 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 6 disposed | 281.74 | 1,690.44 | Form 4, filing 0001209191-20-030498 | |
| 2020-05-15 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 6 disposed | 276.40 | 1,658.40 | Form 4, filing 0001209191-20-030498 | |
| 2020-05-15 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 4 disposed | 282.74 | 1,130.96 | Form 4, filing 0001209191-20-030498 | |
| 2020-05-15 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 2 disposed | 274.37 | 548.74 | Form 4, filing 0001209191-20-030498 | |
| 2020-05-06 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 864 disposed | 274.04 | 236,770.56 | Form 4, filing 0001209191-20-027885 | |
| 2020-05-06 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 416 disposed | 270.35 | 112,465.60 | Form 4, filing 0001209191-20-027885 | |
| 2020-05-06 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 360 disposed | 272.77 | 98,197.20 | Form 4, filing 0001209191-20-027885 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 4
- Open-market sale 75
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Kewalramani Reshma, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001735944
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6